The news story you are looking for has expired. A more recent related article is displayed below.

Sponsored Links

Kamada announces distribution agreement for intravenous alpha-1 antitrypsin (AAT-IV)

Kamada, Ltd., an Israel-based biopharmaceutical company, has entered into an exclusive agreement with a US-based specialty pharmaceutical distribution company for the distribution of its product, intravenous alpha-1 antitrypsin (AAT-IV), in the US.

AAT-IV is an alpha-1 proteinase inhibitor for chronic replacement therapy in individuals who lack alpha-1 antitrypsin and have panacinar emphysema.

Under the terms of the agreement, the US pharmaceutical company will be responsible for the product's distribution and additional activities relating to sales and marketing. Kamada will be responsible for the production and delivery of AAT-IV to the US pharmaceutical company, following its approval by the US Food and Drug Administration (FDA).

In order to maintain exclusivity of the distribution in the US, the US pharmaceutical company will be required to purchase from Kamada minimum quantities of AAT-IV of at least $15 million within the first eighteen months following approval of the product. Thereafter, minimum quantities will depend on sales and reimbursement rates of AAT-IV each year, for the remainder of the term of the agreement.

Deal Type    Partnership
Sub-Category Marketing,Sales,Acquisition of Rights,Distribution
Deal Status  Announced: 2009-08-27

Deal Participants

Partner 1 (Company) Kamada, Ltd.
Partner 2 (Company) Undisclosed - Specialty pharmaceutical distribution company - US

Copyright (C) 2009 Datamonitor Financial Deals Tracker. All rights reserved

News Provided by COMTEX


Related terms: acquisition, fda, israel, marketing, partnership, pharmaceuticals, rates, sales

Related Articles

Radient Pharmaceuticals enters distribution agreement with Grifols USA for DR-70 Onko-Sure -
Oct 9, 2009
...Radient Pharmaceuticals enters distribution agreement with Grifols USA for DR-70...exclusive 5-year marketing and distribution agreement with Grifols USA, LLC. Radient is a pharmaceutical company, while Grifols USA is a distributor...

Charles & Colvard Signs New Distribution Agreement With Stuller
Nov 6, 2009
Click Here Charles & Colvard Signs New Distribution Agreement With Stuller JCK Staff -- JCK Online, 11...today that it has signed a new and expanded distribution agreement with Stuller Inc. Under the terms of the...

Harperscientific Announces Distribution Agreement With ARCS
Oct 16, 2009
... A Printing Office ▪ The Digital Nirvana ▪ Economics and Research Harperscientific Announces Distribution Agreement With ARCS Friday, October 16, 2009 Press release from the issuing company Charlotte, N...

Expanded distribution agreement covers entire Europe
Oct 12, 2009
...to Del.icio.us Expanded distribution agreement covers entire Europe EDN Europe...Nordic Semiconductor has expanded its distribution agreement with Rutronik (Ispringen...Horizons and Sharp sign European distribution agreement 30/10/2009 2. Cross distribution...